Date:August 12, 2025
Meet members of Bio Usawa’s Leadership Team and learn about our Mission to establish end-to-end biologic manufacturing in Africa. Visit our booth for news on our upcoming launch of BioUcenta (ranibizumab)!
Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond.
Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.
Exciting developments in Anti-VEGF therapy are afoot! Anti-VEGF is the gold standard for managing: • Diabetic Macular Edema (DME) • Wet Age-rela…
August 2025It was a great pleasure to welcome Dr. Menghis Bairu, CEO of Bio Usawa Biotechnology Ltd, to discuss their groundbreaking plans to establish a first-of-…
August 2025Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech, a global partner of biopharmaceutical man…
July 2025